The chief executive of Philip Morris International said he was "extremely encouraged" by the U.S. Food and Drug Administration's recent proposal to lower nicotine levels in cigarettes and nudge smokers toward less harmful alternatives such as e-cigarettes.
- J&J ordered to pay $417 million in trial over talc cancer risks
- AstraZeneca ups investment in messenger RNA drugs with Ethris deal
- Parents still failing to put babies to sleep on their backs
- American surgeons poorly prepared for humanitarian operations
- Smokers hospitalized for heart attacks often don't get cessation drugs
BRUSSELS Belgian biscuit maker Lotus Bakeries said it had recalled some of its products in Belgium as they could contain eggs that were contaminated with insecticide fipronil.
(Reuters Health) - Yearly mammograms starting at age 40 would prevent the most deaths from breast cancer, U.S. researchers reported on Monday in a challenge to more conservative recommendations that take into account both the harms and the benefits of screening.
LONDON Britain's Creo Medical Group said its device to remove cancerous lesions in the bowel during an endoscopy had received U.S. approval much quicker than it planned, shaking up a timetable that had been focused on a European launch.
LONDON Novartis is taking aim at drug-resistant malaria – a growing global problem – by launching clinical trials of the first new antimalarial medicine for many years in nine countries across Africa and Asia.